Standout Papers
Citation Impact
Citing Papers
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Sepsis biomarkers: a review
2010 Standout
Biological functions of fucose in mammals
2017
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Haemostatic materials for wound healing applications
2021 Standout
Cerebral venous thrombosis: an update
2007 Standout
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Cocaine-induced acute renal failure, hemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura
2000
Apparent renal disease due to elevated creatinine levels associated with the use of boldenone
2010
Review: Infectious Diseases and Coagulation Disorders
1999
Exosomes: Extracellular organelles important in intercellular communication
2010 Standout
The Thrombospondins
2011 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
Atypical Hemolytic–Uremic Syndrome
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Vascular disorders of the liver # †
2008 Standout
Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients
2008 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
2003
Defining Postpartum Uterine Disease and the Mechanisms of Infection and Immunity in the Female Reproductive Tract in Cattle1
2009 Standout
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
What is Intervertebral Disc Degeneration, and What Causes It?
2006 Standout
Cerebral Sinovenous Thrombosis in the Neonate
2006
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
2000
Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice
2004
Nonchannel drug targets in atrial fibrillation
2004
Physiology of Local Renin-Angiotensin Systems
2006 Standout
IgG4-related disease
2014 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Disseminated Intravascular Coagulation
1999 Standout
Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia
2007
Hemolytic Uremic Syndrome: Recurrence after Renal Transplantation
2000
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study
2000
Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets
2003
Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant
2004
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Circulating microparticles: pathophysiology and clinical implications
2006
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
2009
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions
2005
The immunopathogenesis of sepsis
2002 StandoutNature
Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura
2001
Anti‐CD20 monoclonal antibody (Rituximab) for life‐threatening hemolytic–uremic syndrome
2005
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
2003
Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase family
2001
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
1997
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure
2005
Human Parvovirus B19
2002 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
2001
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Assay of von Willebrand Factor (vWF)-cleaving Protease Based on Decreased Collagen Binding Affinity of Degraded vWF
1999
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
The ADAMTS metalloproteinases
2005
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation
2001 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study
2000
New Fundamentals in Hemostasis
2013
Annexins: From Structure to Function
2002 Standout
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
How I treat patients with thrombotic thrombocytopenic purpura: 2010
2010
Cerebral Venous Thrombosis in Children
2001
von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke
2009
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The TITAN trial – Assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura
2012
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001
Guidelines for the management of hemophilia
2012 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Localization of ADAMTS13 to the stellate cells of human liver
2005
Works of V. Aumann being referenced
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Prevalence of factor V Leiden in children with thrombo-embolism
1996
Serumkonzentrationen der insulinähnlichen Wachstumsfaktoren (IGF)-I und IGF-II sowie der IGF Bindungsproteine (IGFBP)-2 und IGFBP-3 bei 49 Kindern mit ALL, NHL oder soliden Tumoren
1995
Serum levels of insulin-like growth factor-I,-II and insulin-like growth factor binding proteins-2 and-3 in children with acute lymphoblastic leukaemia
1996
Prevalence of factor V Leiden in children with thrombo-embolism
1996
von Willebrand factor cleaving protease and ADAMTS13mutations in childhood TTP
2003